Interestingly, in the context of CRC, elevated expression of all ligands was frequent in tumor-node-metastasis stage I tumors but was seen less frequently in more advanced tumors, indicating an immunoediting mechanism favoring the survival of tumor cells harboring diminished or absent expression of NKG2D ligands (59). The gene discussed is KLRK1; the disease is colorectal carcinoma.